Johnson & Johnson announces US launch of TECNIS Odyssey IOL

News
Article

The TECNIS Odyssey IOL is a new full vision range IOL built on the TECNIS platform.

Odyssey IOL packaging Image credit: Johnson & Johnson

Image credit: Johnson & Johnson

Johnson & Johnson is expanding the launch of its presbyopia-correcting intraocular lense (IOL), TECNIS Odyssey, in the US.

The TECNIS Odyssey IOL is a new full vision range IOL, built on the TECNIS platform from Johnson & Johnson, which according to the company provides two times better contrast in low lighting than PanOptix.1

Peter Menziuso, company group chairman, Vision, Johnson & Johnson, commented on the launch in a release from the company stating, “More than 14,000 eyes have already benefited from TECNIS Odyssey, our new full visual range IOL. TECNIS Odyssey patients have reported outstanding visual outcomes following surgery, which is why we are excited to announce we are expanding the roll-out across the US. Cataract surgery gives patients a once-in-a-lifetime opportunity to improve their sight, and now with this advanced IOL, patients can see clearly at every distance, without the need for glasses.”

TECNIS Odyssey IOLs feature a unique, freeform diffractive surface designed to eliminate the gaps between near, intermediate, and far distances, which offers continuous, uninterrupted vision at all distances, according to the company. Furthermore, 94% of patients who received the IOL were satisfied with their overall vision without glasses.1

In addition to the launch, Johnson & Johnson is launching the “TECNIS Odyssey IOL Peer Connect" which will allow eye care professionals to engage in live virtual clinical discussions, and will help “foster direct and meaningful medical and scientific conversations regarding TECNIS Odyssey IOL between healthcare professionals with expert surgeons who had early access to the technology.”1

In addition to the US, TECNIS Odyssey IOLs have received regulatory approval in Japan, EU, Korea, Canada, Singapore, Australia and New Zealand.

References:
  1. Johnson & Johnson Rolls Out New TECNIS Odyssey Next-Generation Intraocular Lens Offering Cataract Patients Precise Vision at Every Distance in Any Lighting. Press Release; September 30, 2024. Accessed September 30, 2024. https://www2.multivu.com/johnson-johnson/9293351-en-johnson-and-johnson-vision-tecnis-odyssey

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
At CIME 2025, Selina McGee, OD, FAAO, says some patients underestimate oculoplastic care. She stands in front of a sign that says Controversies in Modern Eye Care 2025.
At ASCRS 2025, Alex Hacopian, MD, shares information from his presentation on next-gen presbyopia-correcting intraocular lenses.
Rhue and Canto-Sims talk the value of contact lens patients, financial insights, and key benefits of implementing a contact lens management system.
© 2025 MJH Life Sciences

All rights reserved.